Brief: Caris Life Sciences Launches Caris Chromoseq For Myeloid Malignancies
02/04/2026 14:39
April 2 (Reuters) - Caris Life Sciences Inc CAI.O: CARIS LIFE SCIENCES INC - LAUNCHES CARIS CHROMOSEQ FOR MYELOID MALIGNANCIES Source text: ID:nPnJZgRCa Further company coverage: CAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caris Life Sciences
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Caris Life Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services